BIOCEPT INC Share Price Today: Live Updates & Key Insights

BIOCEPT INC share price today is $null, up null%. The stock opened at $null against the previous close of $null, with an intraday high of $null and low of $null.

BIOCEPT INC Share Price Chart

BIOCEPT INC

us-stock
To Invest in {{usstockname}}
us-stock

BIOCEPT INC Share Price Performance

$null null(null%) null at 23 Mar 2026 12:13 PM Diagnostics & Research
Lowest Today 0.00
Highest Today 0.00
Today’s Open 0.00
Prev. Close 0.00
52 Week High 0.06
52 Week Low 0.00
Day’s Range: Low null High null
52-Week Range: Low 0.00 High 0.06
1 day return -
1 Week return -
1 month return -
3 month return -
6 month return -
1 year return -
3 year return -
5 year return -
10 year return -

BIOCEPT INC Institutional Holdings

BIOCEPT INC Market Status

Strong Buy: 0

Buy: 0

Hold: 1

Sell: 0

Strong Sell: 0

BIOCEPT INC Fundamentals

Market Cap 0.00 M

PB Ratio 9.0E-4

PE Ratio 0.0

Enterprise Value 4.96 M

Total Assets 30.87 M

Volume null

BIOCEPT INC Company Financials

About BIOCEPT INC & investment objective

Company Information Biocept, Inc., a molecular oncology diagnostics company, develops and commercializes proprietary clinical diagnostic laboratory assays designed to identify rare tumor cells and cell-free tumor DNA from blood and cerebrospinal fluid, or CSF in the United States. Its cancer assays provide information to healthcare providers to identify oncogenic alterations that qualify a subset of cancer patients for targeted therapy at diagnosis, progression, and monitoring to identify resistance mechanisms. The company offers assays for solid tumor indications, such as breast cancer, non-small cell lung cancer (NSCLC), gastric cancer, colorectal cancer, prostate cancer, pancreaticobiliary cancer, and ovarian cancer. It also provides cerebrospinal fluid tumor cell and ctDNA and ctRNA testing services to medical oncologists, neuro-oncologists, surgical oncologists, radiation oncologists, urologists, pulmonologists, pathologists, and other physicians; and clinical trial and research services to pharmaceutical companies, biopharmaceutical companies and clinical research organizations. The company has a collaboration with CLEARED4 to develop a system for tracking and managing COVID-19 testing requirements and test results for its customers; and with Protean BioDiagnostics, Inc. to research the ability of its Target Selector molecular assay to determine EGFR status in NSCLC patients. Biocept, Inc. was incorporated in 1997 and is headquartered in San Diego, California. On October 13, 2023, Biocept, Inc. filed a voluntary petition for liquidation under Chapter 7 in the U.S. Bankruptcy Court for the District of Delaware.

Organisation Diagnostics & Research

Employees 50

Industry Diagnostics & Research

CEO null

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

BIOCEPT INC FAQs

What is the share price of BIOCEPT INC today?

The current share price of BIOCEPT INC is $null.

Can I buy BIOCEPT INC shares in India?

Yes, Indian investors can buy BIOCEPT INC shares by opening an international trading and demat account with Motilal Oswal.

How to buy BIOCEPT INC shares in India?

You can easily invest in BIOCEPT INC shares from India by:

Can I buy fractional shares of BIOCEPT INC?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of BIOCEPT INC?

BIOCEPT INC has a market cap of $0.00 M.

In which sector does BIOCEPT INC belong?

BIOCEPT INC operates in the Diagnostics & Research sector.

What documents are required to invest in BIOCEPT INC stocks?

To invest, you typically need:

What is the PE and PB ratio of BIOCEPT INC?

The PE ratio of BIOCEPT INC is N/A and the PB ratio is 0.00.